{"id":"https://openalex.org/W4391592876","doi":"https://doi.org/10.1056/nejmc2313463","title":"SGLT2 Inhibitors and False Positive Toxicology Tests","display_name":"SGLT2 Inhibitors and False Positive Toxicology Tests","publication_year":2024,"publication_date":"2024-02-07","ids":{"openalex":"https://openalex.org/W4391592876","doi":"https://doi.org/10.1056/nejmc2313463","pmid":"https://pubmed.ncbi.nlm.nih.gov/38324493","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11665753"},"language":"en","primary_location":{"id":"doi:10.1056/nejmc2313463","doi":"https://doi.org/10.1056/nejmc2313463","is_oa":false,"landing_page_url":"https://doi.org/10.1056/nejmc2313463","pdf_url":null,"source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11665753/pdf/nihms-2041154.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017385124","display_name":"Aaron L. Schwartz","orcid":"https://orcid.org/0000-0002-8583-1369","observed_orcids":["https://orcid.org/0000-0002-8583-1369"]},"institutions":[{"id":"https://openalex.org/I4210133394","display_name":"Philadelphia VA Medical Center","ror":"https://ror.org/03j05zz84","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210133394","https://openalex.org/I4210147340"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Aaron L. Schwartz","raw_affiliation_strings":["Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center, Philadelphia, PA","Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center, Philadelphia, PA aaron.schwartz@pennmedicine.upenn.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center, Philadelphia, PA","institution_ids":["https://openalex.org/I4210133394"]},{"raw_affiliation_string":"Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center, Philadelphia, PA aaron.schwartz@pennmedicine.upenn.edu","institution_ids":["https://openalex.org/I4210133394","https://openalex.org/I79576946"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5017385124"],"corresponding_institution_ids":["https://openalex.org/I4210133394","https://openalex.org/I79576946"],"apc_list":null,"apc_paid":null,"fwci":1.6559,"has_fulltext":true,"cited_by_count":7,"citation_normalized_percentile":{"value":0.79761169,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"390","issue":"6","first_page":"573","last_page":"574"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.7681000232696533,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.7681000232696533,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.10779999941587448,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11314","display_name":"Clinical Laboratory Practices and Quality Control","score":0.05339999869465828,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9950000047683716},{"id":"https://openalex.org/keywords/empagliflozin","display_name":"empagliflozin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/drug-interference","display_name":"drug interference","score":0.5630000233650208},{"id":"https://openalex.org/keywords/toxicology-testing","display_name":"toxicology testing","score":0.6430000066757202}],"concepts":[{"id":"https://openalex.org/C33070731","wikidata":"https://www.wikidata.org/wiki/Q7218","display_name":"Toxicology","level":1,"score":0.5046728849411011},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.26056474447250366}],"mesh":[{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000431","descriptor_name":"Ethanol","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014556","descriptor_name":"Urine","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":true},{"descriptor_ui":"D014556","descriptor_name":"Urine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D053593","descriptor_name":"Forensic Toxicology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1056/nejmc2313463","doi":"https://doi.org/10.1056/nejmc2313463","is_oa":false,"landing_page_url":"https://doi.org/10.1056/nejmc2313463","pdf_url":null,"source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},{"id":"pmid:38324493","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38324493","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New England journal of medicine","raw_type":"Letter"},{"id":"pmh:oai:pubmedcentral.nih.gov:11665753","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11665753","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11665753/pdf/nihms-2041154.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"N Engl J Med","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:11665753","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11665753","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11665753/pdf/nihms-2041154.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"N Engl J Med","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Zero hunger","id":"https://metadata.un.org/sdg/2","score":0.46000000834465027}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2956425987","display_name":null,"funder_award_id":"IK2 HX003634","funder_id":"https://openalex.org/F4320306127","funder_display_name":"U.S. Department of Veterans Affairs"}],"funders":[{"id":"https://openalex.org/F4320306127","display_name":"U.S. Department of Veterans Affairs","ror":"https://ror.org/05rsv9s98"},{"id":"https://openalex.org/F4320309037","display_name":"Office of Research and Development","ror":"https://ror.org/05rsv9s98"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4391592876.pdf","grobid_xml":"https://content.openalex.org/works/W4391592876.grobid-xml"},"referenced_works_count":4,"referenced_works":["https://openalex.org/W2317716123","https://openalex.org/W2791139055","https://openalex.org/W2981402637","https://openalex.org/W3163936776"],"related_works":["https://openalex.org/W3000421662","https://openalex.org/W2745897374","https://openalex.org/W4386584390","https://openalex.org/W7028314731","https://openalex.org/W4387379520","https://openalex.org/W2399781176","https://openalex.org/W2351865039","https://openalex.org/W4213218904","https://openalex.org/W4211020138","https://openalex.org/W4205563890"],"abstract_inverted_index":{"This":[0],"letter":[1],"describes":[2],"the":[3,19],"case":[4,24],"of":[5,21,38,45],"a":[6,27],"patient":[7,28],"who":[8,29],"had":[9],"multiple":[10],"false":[11],"positive":[12],"toxicology":[13,31],"tests":[14],"for":[15],"urinary":[16],"ethanol":[17],"after":[18],"initiation":[20],"empagliflozin":[22],"therapy.This":[23],"shows":[25],"how":[26],"undergoes":[30],"testing":[32],"may":[33],"be":[34],"harmed":[35],"by":[36],"use":[37],"an":[39],"effective":[40],"and":[41],"increasingly":[42],"used":[43],"class":[44],"medications,":[46],"sodium-glucose":[47],"cotransporter":[48],"2":[49],"(SGLT2)":[50],"inhibitors.":[51]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2024-02-08T00:00:00"}